Ablynx NV (ABLX.BR)
20 Dec 2013
|Market Cap (Mil.):||€338.38|
|Shares Outstanding (Mil.):||48.83|
* Ablynx CEO expects development deals in emerging markets
BRUSSELS, Nov 25 - Ablynx NV : * Sofinnova partners notified that they have dropped below the 3 pct threshold and have sold their complete stake in Ablynx * Biotech Value Fund Partners LP and Biotech Value Fund Inc now hold 2,554,524 Ablynx shares which is 5.23 pct of co's shares
BRUSSELS, Nov 18 - Belgian biotech group Ablynx said on Monday that Paris-based venture capital firm Sofinnova Partners sold its 7.02 percent stake in the group in a private placement worth some 22 million euros ($29.76 million).
BRUSSELS, Nov 18 - Belgian biotech group Ablynx said on Monday that Paris-based venture capital firm Sofinnova Partners, which has a 7.02 percent stake in the group, had launched a private placement to sell shares in the company.
Brussels, Nov 18 - Ablynx NV : * FSMA SAYS SUSPENSION OF TRADING OF ABLYNX SHARES ON THE REQUEST OF THE ISSUER * FSMA - SUSPENSION UNTIL PUBLICATION OF THE RESULTS OF A SALE OF EXISTING SHARES BY ACCELERATED BOOKBUILDING
BRUSSELS, Nov 18 - Ablynx NV : * Shares suspended - regulator
BRUSSELS, Nov 14 - Ablynx NV : * Says 9 months revenues of 16.7 mln euros * Signed exclusive global license agreement with abbvie, potentially worth $840 mln * Deal for development, commercialisation of the anti-il-6r nanobody, alx-0061, in RA and SLE * Net loss for 9-month period was 18.9 mln euros vs 22.3 mln euros last year * Says positive net cash inflow of 0.2 mln euros * Says 9-month operating expenses decreased to 36.2 mln euros vs 45.4 mln last year due to lower research
BRUSSELS, Oct 31 - Ablynx NV : * Says has received notice of a EUR1.68 million in grant funding from the
BRUSSELS - Belgian investment fund Gimv said it sold its remaining stake in biotech firm Ablynx after partnering the company for 12 years.
BRUSSELS, Oct 17 - Belgian investment fund Gimv said it sold its remaining stake in biotech firm Ablynx after partnering the company for 12 years.
Earnings vs. Estimates
Analyst Research Reports
Ablynx NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile